Neogen (NEOG) Other financing activities (2010 - 2026)

Neogen (NEOG) posted quarterly Other financing activities of -$100000.0 for Q2 2026, down 112.17% quarter-over-quarter from $822000.0 in Q1 2026.

Neogen (NEOG) Other financing activities (2010 - 2026) Analysis & Trends

Neogen's Other financing activities history runs 17 years deep, the most recent figure standing at -$100000.0 for Q2 2026.

In Q2 2026, Other financing activities changed N/A year-over-year to -$100000.0; the TTM figure through May 2026 stood at $1.6 million (down 27.27% YoY), while the FY2026 annual figure was $1.6 million, down 27.27% from the prior year.
Other financing activities for Q2 2026 stood at -$100000.0, down from $822000.0 in the prior quarter.
The five-year high for Other financing activities was $1.2 million in Q1 2022, with the low at -$100000.0 in Q2 2026.
The 5-year median for Other financing activities is $252000.0 (2023), against an average of $512294.1.
The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 5173.91% in 2024, then tumbled 125.71% in 2025.
Neogen's Other financing activities stood at $15000.0 in 2022, then soared by 1020.0% to $168000.0 in 2023, then plunged by 37.5% to $105000.0 in 2024, then sank by 125.71% to -$27000.0 in 2025, then tumbled by 270.37% to -$100000.0 in 2026.
Business Quant data shows NEOG's Other financing activities at -$100000.0 in Q2 2026, $822000.0 in Q1 2026, and -$27000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Neogen	2.56 Bn	2.37 Bn	107.80 Mn

Download Data